Phase II study of D.651, an oral vaccine
Phase II study of D.651, an oral vaccine designed to prevent recurrences of vulvovaginal candidiasis
β
D.A. Levy; J.M. Bohbot; F. Catalan; G. Normier; A.M. Pinel; L. Dussourd d'Hinter
π
Article
π
1989
π
Elsevier Science
π
English
β 407 KB